The US Food and Drug Administration (FDA) is planning to regulate the use of the cannabis compound CBD in food and supplements after weighing the evidence on the compound's safety.
The FDA will decide whether regulating legal cannabis will require new agency rules or new legislation from Congress.
Cannabis products, excluding Epidiolex, are illegal at the federal level in the US, although some states allow their use.
According to Patrick Cournoyer, who heads the FDA office developing the agency's cannabis strategy, the FDA will ascertain if CBD can be safely eaten every day for a long period or during pregnancy amid concerns about future fertility.
.


Central Banks Eye Gold, Reduce Dollar Exposure as AI Adoption Accelerates: OMFIF Survey
Apple Challenges India Antitrust Probe, Says CCI Copied Rivals’ Claims in App Store Case
Supreme Court Blocks 5th Circuit Ruling on Abortion Pill Access
Hantavirus Cruise Ship Outbreak Triggers Global Health Alert
The government is ‘doubling down’ on its social media ban. But bigger penalties for platforms aren’t enough
US Plans Kenya Ebola Quarantine Facility Amid Congo Outbreak
Oil Prices Slip as U.S.-Iran Peace Talks and Strait of Hormuz Risks Keep Markets on Edge
US Tightens Ebola Controls as Congo Outbreak Sparks Global Concern
Argentina Economy Shrinks 1.5% in April, Recovery Under Milei Loses Momentum
Meta Seeks Legal Shield From Child-Harm Lawsuits Amid KOSA Talks
Morgan Stanley Raises Tesla Q2 Delivery Forecast on Strong Europe and China Demand
South Korea Ex-President Yoon Suk Yeol Sentenced to 30 Years Over Martial Law Plot
RBA Minutes Signal Australia Central Bank Remains Ready to Raise Interest Rates if Inflation Persists
GSK Reportedly Nears $9 Billion Acquisition of Cancer Drug Developer Nuvalent
Baige Online Shares Soar 333% in Hong Kong IPO Debut as AI Insurance Demand Lifts Chinese Listings 



